Residency · Indianapolis, IN
Sponsored by Indiana University School of Medicine
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
JAMA · 2023 · 2,315 citations · Liana Apostolova
The TRIPOD-LLM reporting guideline for studies using large language models.
Nature medicine · 2025 · 345 citations · Judy Gichoya
Lecanemab: Appropriate Use Recommendations.
The journal of prevention of Alzheimer's disease · 2023 · 755 citations · Liana Apostolova
Donanemab in Early Alzheimer's Disease.
The New England journal of medicine · 2021 · 1,335 citations · Liana Apostolova
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.
The New England journal of medicine · 2024 · 357 citations · Jason Allen
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 424 citations · Paul Haste
Assessing the potential of GPT-4 to perpetuate racial and gender biases in health care: a model evaluation study.
The Lancet. Digital health · 2024 · 332 citations · Judy Gichoya
Donanemab: Appropriate use recommendations.
The journal of prevention of Alzheimer's disease · 2025 · 180 citations · Liana Apostolova